![]() |
|
|
Vol. 15, Issue 8, 3591-3604, August 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





* Institute of Pathology, University of Oslo, 0027 Oslo, Norway;
Department of Biochemistry, The Norwegian Radium Hospital, 0310 Oslo, Norway
Submitted January 16, 2004;
Accepted June 2, 2004
Monitoring Editor: Suzanne Pfeffer
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The exact role of Cbl in EGFR endocytosis has not been resolved. Overexpression of wild-type Cbl increased, whereas overexpression of Cbl mutants with abolished ubiquitin ligase activity decreased the rate of endocytosis (Thien et al., 2001
). Fluorescence energy transfer studies demonstrated that localization of Cbl-YFP to endosomes depended on a proline-rich domain of Cbl that interacts with Grb2. Also, although direct binding of Cbl to phosphotyrosine 1045 of the EGFR was required for maximal EGFR ubiquitination, this direct binding was not essential for localization of Cbl to EGFR-containing endosomes. These data suggested that binding of Cbl to EGFR through Grb2 is necessary and sufficient for Cbl function in clathrin-mediated endocytosis. However, these data were interpreted to mean that ubiquitination of the EGFR is not essential (Jiang and Sorkin, 2003
). It has further been reported that EGFR endocytosis is independent of Cbl's ubiquitin ligase activity, but that Cbl is required to link the EGFR to CIN85, and thereby recruit endophilin to EGFR-Cbl complexes (Soubeyran et al., 2002
). The requirement for Cbl-induced ubiquitination of EGFR was, however, supported by the finding that human Sprouty 2 (hSpry2) inhibited ligand-induced EGFR endocytosis (Fong et al., 2003
). hSpry2 binds Cbl both constitutively and in an EGF-dependent manner and inhibits Cbl-dependent ubiquitination of the EGFR (Wong et al., 2002
; Fong et al., 2003
).
Eps15 as well as epsin 1 and 2 are proteins involved in early steps of endocytosis that harbor ubiquitin-interacting motifs (UIMs; Tebar et al., 1996
; Benmerah et al., 1998
; Chen et al., 1998
; Polo et al., 2002
). UIMs of epsins and Eps15 bind directly to ubiquitin (Polo et al., 2002
; Shih et al., 2002
; Aguilar et al., 2003
). In yeast, it was recently demonstrated that Ent1, Ent2, and Ede1 (the homologues of human epsins 1 and 2 and Eps15, respectively) have redundant functions in internalization of the pheromone receptor Ste2 (Shih et al., 2002
). The endocytic defect of a triple Ent1-Ent2-Ede1 knockout was rescued by wild-type Ent1, but not by an Ent1 mutant in which the UIMs were deleted (Shih et al., 2002
). This, together with the findings that a chimeric Ste2-ubiquitin molecule, where the whole cytoplasmic tail of Ste2 was replaced by ubiquitin, could be efficiently internalized (Shih et al., 2002
), strongly suggest that intracellular ubiquitin-binding proteins can work efficiently as endocytic cargo adaptors in yeast. However, the same has so far not been demonstrated in mammalian cells.
In this study we set out to dissect the precise function of Grb2 and the role of ubiquitination and proteins with ubiquitin-interacting domains in clathrin-mediated endocytosis of EGFR. Our findings suggest that the Grb2-Cbl complex recruits the EGFR to forming clathrin-coated pits by interacting with an Eps15-containing macromolecular complex. Our findings further indicate that Cbl-induced ubiquitination, as well as interaction of conjugated ubiquitin with endocytosis proteins harboring ubiquitin interacting domains, is required for EGF-induced endocytosis of the EGFR.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture and Treatment
The laryngeal carcinoma cell line Hep2 and HeLa cells were grown in Dulbecco's modified Eagle's medium (DMEM) with penicillin-streptomycin mixture, and L-glutamine (2 mM), all from BioWhittaker (Walkersville, MD). FCS (5% vol/vol; PAA Innovations, Linz, Austria) was routinely used. The cells were plated at a density of 15,000 cells/cm2 48 h before experiments. In pulse-chase experiments, cells were incubated with ligand in MEM without bicarbonate with 0.1% BSA on ice for 15 min, followed by washing three times in ice-cold PBS to remove unbound ligand and subsequent chase in ligand-free MEM without bicarbonate at 37°C.
Plasmids and Transient Transfection of Cells
HeLa cells were transiently transfected with d.n. Grb2, H-Ras17N, wt UbRGG, UbR, UbR L8A/I44A, and hSpry2 using Fugene or Effectene 48 h upon plating. Transfected cells were analyzed 24 or 48 h upon transfection. D.n. Grb2 (W36, 193K; nonfunctional N- and C- terminal SH3 domains) was provided by Robin M. Scaife (University of Western Australia, Nedlands, Australia). This construct was originally made by Lyuba Varticovski (Tufts University Scholl of Medicine, Boston, MA; Tanaka et al., 1995
; Jain et al., 1997
). D.n. Grb2 was amplified by PCR, and a Myc fusion protein of d.n. Grb2 was made by subcloning into a pRK5Myc vector provided by Alan Hall (UCL, London, United Kingdom). Hemagglutinin (HA)-tagged dominant negative H-Ras (S17N) in pcDNA3.1 was purchased from Guthrie cDNA Resource Center (Guthrie Research Institute, Sayre, PA). The pMT123 plasmid encoding HA-Ubiquitin x 8 was obtained from Dirk Bohmann (University of Rochester, Rochester, NY). From this plasmid the constructs pcDNA3-Myc-UbRGG, pcDNA3-Myc-UbR, and pcDNA3-Myc-UbR L8A/I44A were made by PCR mutagenesis of the ubiquitin sequence and subcloning behind the Myc epitope of pcDNA3-Myc (Raiborg et al., 2001
). GFP-tagged Sprouty (hSpry2; in pEGFP) was obtained from Graeme Guy (Institute of Molecular and Cell Biology, Singapore).
Antibodies
Rabbit anti-epsin antibody was a gift from Linton Traub (University of Pittsburgh School of Medicine, Pittsburgh, PA). Rabbit anti-clathrin light chain antibody was a gift from Frances M. Brodsky (University of California, San Francisco, CA). Mouse anti-Myc antibody was from the 9E10 hybridoma (Evan et al., 1985
). Rabbit anti-Myc (ab9106) and rabbit anti-GFP were from Abcam Ltd. (Cambridge, United Kingdom). Rabbit anti-EGF, rabbit anti-Grb2, rabbit anti-Cbl, mouse anti-EGFR (sc-120), and mouse anti-ubiquitin antibody (P4D1) were from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse anti-EGFR (antibody-3) was from Neomarkers (Fremont, CA). Rabbit anti-Eps15 (C-term) was from BAbCO (Richmond, CA), and rabbit anti-human transferrin receptor antibody from HybriDomus (Hellebaek, Denmark). Mouse anti-human dynamin antibody (Hudy 1) was a gift from Sandy Schmid (Scripps Research Institute, San Diego, CA). Mouse anti-HA antibody was from Zymed Laboratories Inc. (South San Francisco, CA). Mouse anti-FLAG and peroxidase-conjugated goat anti-rabbit antibodies were from Sigma-Aldrich. Rabbit anti-mouse IgG was from Cappel, ICN Biomedicals (Costa Mesa, CA). Rhodamine Red-Xconjugated donkey anti-mouse and Rhodamine Red-Xconjugated donkey anti-rabbit antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA). Alexa Fluor 488conjugated goat anti-rabbit and anti-mouse antibodies were from Molecular Probes. Rabbit anti-pMAPK antibody was from Cell Signaling Technology (Beverly, MA).
Immunocytochemistry and Confocal Microscopy
Cells were plated on 12-mm coverslips (Menzel-Gläser, Braunschweig, Germany). On experiments, cells were washed twice in PBS and fixed with paraformaldehyde (4% wt/vol; Riedel-deHaën AG, Hannover, Germany) in Soerensen's phosphate buffer for 20 min on ice. Cells were washed three times with PBS before permeabilization with Triton X-100 (0.1% wt/vol in PBS) for 10 min. The fixed and permeabilized cells were preincubated with BSA (1% wt/vol in PBS) for 30 min before incubation with primary antibodies for 1 h. The coverslips were washed with PBS and incubated with secondary antibodies for 30 min before washing and mounting with Dako fluorescent mounting medium or Mowiol. The cells were examined using a Leica TSC XP confocal microscope (Leica Microsystems AG, Wetzlar, Germany) or a Zeiss LSM510 Meta confocal microscope (Carl Zeiss Microscopy, Göttingen, Germany).
Immunoelectronmicroscopy
Cells, treated as described in legends to figures, were fixed with paraformaldehyde (4% wt/vol) and glutaraldehyde (0.1% wt/vol) in Soerensen's phosphate buffer and processed for cryosectioning and immunolabeling (Griffiths et al., 1984
). Bound antibodies were visualized using protein A gold (purchased from G. Posthuma, Utrecht, The Netherlands). When the primary antibody was mouse IgG, incubation with rabbit anti-mouse IgG was used as an intermediate reagent between the primary antibody and protein A gold. The sections were examined using a Philips CM 120 electron microscope (Eindhoven, The Netherlands).
125I-EGF Internalization Experiments
Cells were incubated as described in legends to figures. The radioactivity in the medium was measured in a gamma-counter (1470 Wizard; Wallac, Turku, Finland). The cells were washed three times with PBS and treated with sodium acetate buffer (0.2 M) containing NaCl (0.5 M) adjusted to pH 4.5 or 7.4 (SAB pH 4.5/SAB pH 7.4) on ice for 10 min. The 125I-EGF associated with the cells was precipitated using TCA-phosphotungstic acid. Finally, the precipitated material was dissolved in NaOH (1 M), and the radioactivity was measured. The radioactivity associated with cells treated with SAB pH 4.5 represents internalized 125I-EGF, and radioactivity from cells treated with SAB pH 7.4 represents total cell-associated 125I-EGF.
125I-Tf Interaction Experiments
Human Tf (iron-saturated, 10 µg in 40 µl of PBS) was labeled with 0.5 mCi of I125 (as NaI, carrier-free) by incubation with Iodogen (Pierce, Rockford, IL). Iodinated Tf was separated from the free iodide on a Sephadex G-25 column (PD-10 G25M; Amersham Biosciences). The specific activity of iodinated Tf was 7.5 x 107 cpm/ng. Internalization of Tf was measured after pronase treatment of cells, as described (Ciechanover et al., 1983
). The medium was removed, and the cells were washed three times with ice-cold PBS and treated with 0.3% pronase in cold MEM containing BSA (1%), on ice for 60 min. On centrifugation, the radioactivity in the supernatant and pellet fractions was measured in a gamma-counter. The radioactivity in the pellet fraction represents internalized 125I-Tf.
| RESULTS |
|---|
|
|
|---|
25% of the labeling of EGF and the EGFR at the plasma membrane was within coated areas compared with 23% EGFR in coated pits in control cells (unpublished data). Most coated areas observed upon incubation with EGF on ice were flat, and only a limited fraction (
10%) of the labeling of EGF and EGFR was associated with invaginated coated pits. Double-labeling for EGF and clathrin or for EGFR and clathrin confirmed that the coated areas indeed contained clathrin.
|
Mutant Grb2 Inhibits EGF-induced Relocalization of the EGFR to Clathrin-coated Pits
It was previously demonstrated that Grb2 incapable of binding proline-rich sequences due to amino acid substitutions in the SH3 domains inhibited the endocytosis of the EGFR (Jiang et al., 2003
). To investigate in more detail at what step of endocytosis a dominant negative (d.n.) Grb2 inhibited EGF-induced clathrin-dependent endocytosis, we overexpressed Myc-tagged W36, 193K Grb2 in Hep2 cells and analyzed the cells upon incubation with 60 ng/ml EGF on ice for 60 min by immuno-EM. In nontransfected cells, the EGF-EGFR complex was found in coated areas of the plasma membrane, as demonstrated in Figure 1. However, in cells overexpressing d.n. Grb2, labeling for the EGF-EGFR complex was restricted to smooth areas of the plasma membrane, and no labeling was found in coated pits (Figure 2A). The d.n. Grb2 mutant was further overexpressed in HeLa cells, which are more readily transfected, and the effect on endocytosis and localization to coated pits was again studied by immuno-EM. In nontransfected cells (Figure 2B), the EGF-EGFR complex was efficiently endocytosed upon incubation with 60 ng/ml EGF at 37°C for 10 min, and labeling for EGF was found in multivesicular endosomes. It should be noted that such high concentrations of EGF induce both clathrin-dependent and -independent endocytosis as EGF-induced endocytosis of EGFR through clathrin-coated pits is saturable (Lund et al., 1990
; Wiley et al., 1998
). In cells overexpressing d.n. Grb2, endocytosis of EGF-EGFR was strongly inhibited, consistent with a potential inhibitory effect of d.n. Grb2 on both clathrin-dependent and -independent endocytosis. No labeling was found in coated pits, and the labeling for EGF was restricted to smooth areas of the plasma membrane (Figure 2, CE). Endocytosis of the Tf-receptor (TfR) was not inhibited by overexpression of d.n. Grb2 (Figure 2, FH), and labeling for TfR was found both in coated pits and in coated vesicles. In accordance with the data published by Jiang et al. (2003
), these data indicate that Grb2 is involved in recruiting the activated EGFR to clathrin-coated pits, whereas Grb2 is not involved in endocytosis of the TfR.
|
Ras Activity Is not Required for Clathrin-dependent EGFR Endocytosis
Grb2 appears to be constitutively associated with Cbl as well as with the Ras GDP/GTP exchange factor Sos (Jiang et al., 2003
). On activation of the EGFR, Grb2-Sos is recruited to the EGFR, and this results in activation of Ras. Because activation of Ras has been demonstrated to be essential for endocytosis of the EGFR (Barbieri et al., 1998
; Tall et al., 2001
) and has further been demonstrated to be involved in initiation of macropinocytosis (Amyere et al., 2002
), we wanted to investigate whether the inhibitory effect of d.n. Grb2 on clathrin-dependent endocytosis of EGF-EGFR could be explained by inhibited Ras activity. To investigate the role of Ras activity in EGF-induced EGFR endocytosis, we studied the effect of overexpressing d.n. Ras (H-Ras17N) on endocytosis of EGF and of Tf. By confocal microscopy studies, we observed no inhibition of endocytosis of Alexa488-EGF in transfected HeLa cells compared with in nontransfected cells when 15 ng/ml EGF was added (Figure 3A). However, when high concentrations of EGF (60150 ng/ml) were used, a slight inhibition was observed (unpublished data). This probably reflects the inhibitory effect of H-Ras17N on EGF-induced macropinocytosis (Amyere et al., 2002
). Immuno-EM confirmed that EGF was endocytosed in H-Ras17N transfected cells incubated with 60 ng/ml EGF (unpublished results).
|
We also investigated the effect of overexpressing H-Ras17N on endocytosis of Tf. As demonstrated in Figure 3A, there was no effect of H-Ras17N on endocytosis of Alexa488-Tf. Overexpressing H-Ras17N significantly reduced phosphorylation of MAPK upon addition of EGF (Figure 3B), demonstrating that the expression of H-Ras17N affected intracellular signaling. Because EGF-induced endocytosis of EGFR through clathrin-coated pits is saturable (Lund et al., 1990
; Wiley et al., 1998
), we additionally performed an internalization assay using a low concentration of 125I-EGF (1 ng/ml) in order to quantify the effect of H-Ras17N on clathrin-dependent endocytosis of the EGFR. As demonstrated (Figure 3C), overexpression of H-Ras17N did not inhibit the clathrin-dependent endocytosis of 125I-EGF. Altogether, this argues that Ras activity is not important in EGF-induced clathrin-dependent endocytosis and that the inhibitory effect of d.n. Grb2 on clathrin-dependent endocytosis occurring at low concentrations of EGF cannot be explained by inhibited Ras activity.
Grb2 and Cbl Localize at the Rim of Clathrin-coated Pits in an EGF-dependent Manner
Grb2-mediated interaction of Cbl with the EGFR has been demonstrated to be required for efficient ubiquitination of the EGFR (Waterman et al., 2002
; Jiang et al., 2003
). A potential explanation for the requirement of Grb2 for recruitment of EGFR to coated pits is that Cbl-dependent ubiquitination is required for the EGFR to enter coated pits. It was reported that Grb2 colocalized with the
2 subunit of AP-2 and EGF upon incubation of PAE cells with EGF for 1 h at 4°C (Jiang et al., 2003
). We have previously demonstrated that the EGFR colocalizes with Cbl at the plasma membrane under similar conditions (Longva et al., 2002
), and it has also been shown that Eps15 is recruited to the plasma membrane when cells are incubated with EGF on ice (Torrisi et al., 1999
). As expected, we found by immunofluorescence and confocal microscopy that incubation of Hep2 cells with EGF on ice for 60 min recruited Grb2, Cbl, and Eps15 to the plasma membrane (Figure 4A). The recruitment of these molecules was more efficient upon incubation with EGF for 60 min than for 15 min on ice (unpublished data).
|
The plasma membrane localization of Grb2 and Cbl was further studied by immuno-EM. When sections from the same specimens as used in Figure 1 were labeled with antibodies to Grb2 (Figure 4B, IIV) or antibodies to Cbl (Figure 4B, VVIII), both Grb2 and Cbl were found at the plasma membrane. Grb2 and Cbl localized to both smooth and coated plasma membrane areas. Approximately 15% of Grb2 at the plasma membrane and 25% of Cbl at the plasma membrane were associated with coated regions (see Figure 4B). However, although EGF and EGFR labeling appeared randomly distributed along the coat (see Figure 1), labeling for Grb2 and Cbl was restricted to the rim of the coat, both in flat and in fully invaginated clathrin-coated pits. A similar localization to the rim of clathrin-coated pits has previously been shown for Eps15 (Tebar et al., 1996
; Stang et al., 2000
). The observations that Grb2, Cbl, and Eps15 are not found within the coat could theoretically be caused by poor antigen accessibility to EGFR-associated proteins within the coat. This cannot formally be ruled out, but is, however, unlikely, as we have previously detected the EGFR within coated pits using antibodies directed to the intracellular domain of the EGFR (Stang et al., 2000
). Also, labeling for the Eps15-interacting protein epsin was found all along the coat (Figure 5, AC) and showed the same distribution as did dynamin (Figure 5, D and E) and the
-adaptin subunit of AP-2 (unpublished results). Interestingly, epsin, which has been found to modify membrane curvature (Ford et al., 2002
), localized to both flat and to fully invaginated clathrin-coated pits, showing that recruitment of epsin does not per se cause invagination of coated pits. The finding that incubation with EGF recruits Grb2 and Cbl to the rim of coated pits where also Eps15 has been demonstrated to localize (Tebar et al., 1996
; Stang et al., 2000
), suggests that these proteins cooperate in the recruitment of EGFR to clathrin-coated pits. The finding that the EGFR dissociates from Grb2 and Cbl when the EGFR enters central parts of clathrin-coated pits is consistent with our previous finding that the EGFR is transiently dephosphorylated upon recruitment to coated pits (Stang et al., 2000
). The described dephosphorylation could either be due to transient inhibition of the EGFR kinase or to transient activation of a phosphatase dephosphorylating the EGFR in coated pits. Clarification of this requires further studies.
|
Differential Localization of EGFR and TfR in Clathrincoated Pits at the Plasma Membrane
Labeling for epsin revealed that the labeling density in coated plasma membrane domains varied. Although some coats showed a strong labeling, the labeling of others were weak or negative (unpublished results). This could suggest that epsin is either recruited at a late stage of coated pit formation or that epsin is recruited only to a limited set of coated pits. It has been suggested that epsin is an adaptor protein that recruits ubiquitinated receptors to coated pits (Shih et al., 2002
). To investigate whether epsin was restricted to coated pits containing ubiquitinated receptors, we compared the colocalization of EGFR and epsin with the colocalization of TfR and epsin using Hep2 cells and immuno-EM. It has been debated whether the EGFR and the TfR are recruited to different coated pits or whether the two receptors share common coated pits. We therefore initially quantified the extent of colocalization of EGFR and TfR. In cells incubated with EGF on ice for 60 min, we found a limited colocalization of the two receptors. Double-labeling for EGFR and TfR showed that although 15% of the labeled coated areas were positive for both receptors, 19% were positive for the EGFR only, and the remaining 66% were positive for the TfR only (Table 1A). Double-labeling for EGF and TfR gave similar results with 14% double positive coated areas, 32% positive for EGF only, and 54% positive for the TfR only (Table 1 A). Double-labeling for EGF and epsin showed that not all EGF-containing coats were epsin positive (Table 1B). Although 23% of the positive coats labeled for both EGF and epsin, 31% labeled for EGF only and 46% for epsin only. A similar double-labeling for TfR and epsin showed that as much as 42% of the positive coats labeled for both TfR and epsin, 22% labeled for TfR only and 36% for epsin only (Table 1B). This argues that epsin does not preferentially associate with EGFR positive clathrin-coated pits.
|
Overexpression of hSpry2 Inhibits EGF-induced Relocalization of the EGFR into Clathrin-coated Pits
hSpry2 has been demonstrated to bind Cbl and to inhibit ligand-induced ubiquitination and endocytosis of the EGFR (Wong et al., 2002
; Fong et al., 2003
). To address the potential impact of Cbl-dependent ubiquitination on EGFR endocytosis, we overexpressed GFP-tagged hSpry2 in HeLa cells. We first confirmed that overexpression of hSpry2-inhibited ubiquitination of the EGFR. HeLa cells were transfected with a plasmid encoding HA-Ubiquitin and with or without plasmids encoding hSpry2 or d.n. Grb2. As demonstrated in Figure 6A, both hSpry2 and d.n. Grb2 efficiently inhibited ubiquitination of EGFR upon incubation of transfected cells with EGF for 60 min on ice and for 5 min at 37°C. When cells were incubated at 37°C for 15 min upon binding fluorescing EGF, the transfected cells were observed to inefficiently endocytose EGF, in the sense that hSpry2 reduced the number of endocytic vesicles containing fluorescent EGF, whereas the number of endocytic vesicles containing fluorescent Tf was unchanged (Figure 6B). The sensitivity of this assay is limited by the intensity of the vesicle fluorescence, and it is potentially possible that small early endosomes could be below the detection limit of the confocal microscope. Furthermore, hSpry2-dependent reduction in ubiquitination of the EGFR will affect the endosomal sorting of EGFR. We therefore directly assayed the clathrin-dependent endocytosis of EGF-EGFR using low concentrations of 125I-EGF and short times of incubation at 37°C upon binding. As demonstrated in Figure 6C, the internalization assay demonstrated that endocytosis as such was inhibited.
|
The EGF-induced localization of hSpry2 and EGFR in HeLa cells incubated with EGF on ice was further investigated by immuno-EM. At the plasma membrane, overexpressed hSpry2 (anti-GFP labeling) localized mainly to smooth membrane areas. However, a limited amount of the labeling was associated with coated membrane areas (Figure 7). Double-labeling for GFP-hSpry2 and clathrin confirmed that the coats contained clathrin (Figure 7C), and interestingly, hSpry2 was found to localize to the rim and not to the central parts of the clathrin coats. Most strikingly, double-labeling for GFP-hSpry2 and EGF, or the EGFR, showed that, compared with in nontransfected cells, in which EGF and EGFR were found to localize to central parts of coated pits (see Figure 1), EGF (Figure 7, D and E) and EGFR (Figure 7F) were found at the rim of coated pits in cells overexpressing hSpry2. Double-labeling for GFP-hSpry2 and Grb2 (Figure 7G) or Cbl (unpublished results) showed that all three proteins localized to the rim of coated pits also in cells overexpressing hSpry2. This strongly suggests that ubiquitination, induced by plasma membrane-localized Cbl, is essential in guiding the EGFR into coated pits, but that overexpression of hSpry2 counteracts this Cbl-mediated guiding of activated EGFR.
|
Monoubiquitin-binding Proteins Are Essential for Endocytosis of EGFR
The finding that Cbl seems to be important for recruiting activated EGFR to clathrin-coated pits suggests that Cbl-induced ubiquitination is essential in this translocation process. An explanation for the potential requirement for ubiquitination is the ability of ubiquitinated proteins to interact with proteins harboring UIMs or other ubiquitin-binding domains. To directly address the impact of interaction of ubiquitin with ubiquitin-binding domains on endocytosis of activated EGFR, we transiently transfected Hep2 cells and HeLa cells with a plasmid encoding ubiquitin lacking C-terminal glycines (residues 7576 deleted). This mutant ubiquitin (UbR) cannot be conjugated to substrates, but binds noncovalently to ubiquitin interacting domains. Therefore, upon overexpression, UbR will block interaction of ubiquitinated proteins with proteins harboring sequence motifs known to bind directly to monoubiquitin. To counteract interaction of the overexpressed ubiquitin with such motifs, a plasmid encoding ubiquitin with the L8A/I44A mutations was created in the context of the deletion mutant UbR (UbR L8A/I44A). The double mutation (L8A/I44A) and the single mutation (I44A) have both been demonstrated to efficiently inhibit interaction of ubiquitin with UIMs (Beal et al., 1996
; Shih et al., 2002
) as well as with other ubiquitin-binding domains (Kang et al., 2003
; Alam et al., 2004
; Shiba et al., 2004
). All the ubiquitin constructs were Myc-tagged in order to facilitate detection of exogenously expressed protein. On transfection and overexpression in Hep2 cells (unpublished data) and HeLa cells (Figure 8), conjugation of Myc-ubiquitin to cellular proteins could be observed by Western blotting with antibody recognizing Myc. As demonstrated in Figure 8A (top panel), conjugation was absent upon expression of UbR, but was observed in the case of full-length ubiquitin (UbRGG). Consistently, a pool of Myc-tagged nonconjugated ubiquitin was observed by Western blotting lysate from cells transfected with UbR (Figure 8A, top panel). When the same lysates were immunoblotted with antibody recognizing monomeric and conjugated ubiquitin (Figure 8A, bottom panel), it was observed that the amount of free nonconjugated ubiquitin was significantly increased in cells transfected with UbR. Because only 40% of the cells were transfected, the amount of free ubiquitin in the transfected cells is underestimated. This is further demonstrated by immunostaining of untransfected and UbR-transfected cells with antibodies to Myc and to ubiquitin (Figure 8B), directly demonstrating overexpression of UbR in single cells.
|
The effect of overexpressing UbR and UbR L8A/I44A in Hep2 cells on endocytosis of the EGFR was studied using Rhodamine-EGF. As demonstrated, although UbR efficiently inhibited endocytosis of EGF compared with nontransfected cells (Figure 9A), there was no observable effect on endocytosis of EGF by overexpressing UbR L8A/I44A (Figure 9D). The same was observed when studying localization of the EGFR in EGF-activated cells by immunofluorescence (Figure 9B). When the same experiment was performed with Alexa594-Tf, no effect on endocytosis was observed upon overexpression of UbR (Figure 9C), nor of UbR L8A/I44A (see Figure 10). To quantify the effect of overexpressing UbR on endocytosis of the EGFR, transfected cells with or without fluorescing vesicles were counted, and the percentage of transfected cells with vesicular staining was estimated. As demonstrated in Figure 10, only overexpression of UbR significantly inhibited the endocytosis of EGF-EGFR. The inhibitory effect was stronger when 10 ng/ml fluorescent EGF was used than upon incubation with 10-fold more EGF. These experiments indicate that monoubiquitin-interacting proteins are involved in the ligand-induced clathrin-dependent endocytosis of the EGFR, but not the constitutive clathrin-dependent endocytosis of the TfR. The experiments further indicate that macropinocytic uptake of EGFR induced upon addition of high concentrations of EGF (100 ng/ml; Figure 10) is not ubiquitin dependent.
|
|
Because lack of interaction of ubiquitinated proteins with proteins harboring ubiquitin-interacting motifs could inhibit initial steps of endocytosis as well as transfer of EGFR from early small endosomes to larger endosomes detectable by confocal microscopy, we directly investigated whether overexpression of UbR affected recruitment of the EGFR into clathrin-coated pits by immuno-EM. Sections of UbR-transfected Hep2 cells incubated with EGF for 60 min on ice were double-labeled with antibodies to Myc and to EGF or EGFR. Quantitations of the labeling showed that EGF-induced recruitment of EGFR into coated pits was strongly reduced upon expression of UbR (see Figure 11). Compared with nontransfected cells within the same specimen (see also Figure 1), the amount of EGF-EGFR localizing to coated pits in UbR-positive cells was reduced by
65%, confirming the role of ubiquitination in recruitment of the EGFR to clathrin-coated pits. We further investigated whether localization of the UIM-containing protein epsin to clathrin-coated pits was altered in cells overexpressing UbR. Sections of UbR-transfected Hep2 cells incubated with EGF (as described above) were double-labeled with antibodies to Myc and to epsin. Compared with nontransfected cells within the same specimen, the amount of epsin localizing to coated pits appeared unaltered (unpublished data). This suggests that epsin-ubiquitin interactions are not required for recruitment of epsin to clathrin-coated pits.
|
| DISCUSSION |
|---|
|
|
|---|
Grb2 and Cbl were interestingly found to specifically localize to the rim of EGFR-positive clathrin coats in the same manner as previously reported for Eps15 (Torrisi et al., 1999
; Stang et al., 2000
). We have further demonstrated that also hSpry2 localizes to the rim of coated pits in transfected cells. hSpry2 interacts with Cbl both constitutively and inducibly, and this interaction inhibits ubiquitination of the EGFR (Wong et al., 2002
; Fong et al., 2003
; and the current study). We found the inhibition of EGFR ubiquitination induced upon overexpression of hSpry2 to correlate with inhibited translocation of activated EGFR to the central parts of clathrin-coated pits, and we observed that EGF-EGFR accumulated at the rim of clathrin-coated pits in cells overexpressing hSpry2. This finding clearly illustrates that ubiquitination is required for translocation of the EGFR into clathrin-coated pits.
Several investigators have concluded that Cbl is important for endocytosis of EGFR (Lill et al., 2000
; Thien et al., 2001
; Soubeyran et al., 2002
; Waterman et al., 2002
; Wong et al., 2002
; Haglund et al., 2003
; Jiang and Sorkin, 2003
; Mosesson et al., 2003
). However, the importance of ubiquitination per se in this process has been debated (Soubeyran et al., 2002
; Waterman et al., 2002
; Duan et al., 2003
; Jiang and Sorkin, 2003
; Schmidt et al., 2003
). The fact that a clear conclusion has been difficult to reach on this point could possibly be explained by the experimental design of these studies. In most cases the potential importance of ubiquitination has been addressed by overexpressing catalytically inactive mutants of Cbl (Thien et al., 2001
; Jiang and Sorkin, 2003
) or by overexpressing deletion mutants of Cbl (Longva et al., 2002
). In these cases there will likely be residual catalytic activity due to presence of endogenous Cbl and due to the fact that catalytically inactive mutants of Cbl do not act in a true dominant interfering manner. This also applies to the study where knockout mice for Cbl were created, because in these mice only the c-Cbl isoform was knocked out and Cbl-b was not targeted (Duan et al., 2003
).
The ubiquitin internalization signal is distinct from linear internalization sequences (tyrosine- or di-leucine-sequences) that promote internalization by binding to AP-2. Consistently, AP-2 was found not to be required for direct interaction with the EGFR for clathrin-dependent internalization of the EGFR (Huang et al., 1999
; Nesterov et al., 1999
). Furthermore, it was recently reported that the EGFR was efficiently endocytosed even in the absence of AP-2 upon RNA interference knock-down (Conner and Schmid, 2003
; Motley et al., 2003
). This could be consistent with the possibility that ubiquinated EGFR interacts directly with an endocytosis adaptor harboring a ubiquitin-interacting domain. Epsin, which contains an ENTH domain at the N-terminus, two UIMs, and EH-, clathrin- and AP-2 interaction motifs at the C-terminus, has been suggested to function as an adaptor in endocytosis (Wendland, 2002
). However, our finding that EGFR localized to the central part of clathrin-coated pits lacking epsin, suggests that such parts of coated pits contain other, yet undefined, functional ubiquitin binding proteins.
On overexpressing H-Ras17N, EGF-induced phosphorylation of MAPK was clearly inhibited. However, clathrin-dependent endocytosis of the EGFR, assayed by nonsaturating concentrations of EGF (1 ng/ml) was not inhibited, whereas overexpression of H-Ras17N to some extent inhibited endocytosis of EGFR when cells were incubated with 60150 ng/ml EGF. This is consistent with a role for Ras in EGF-induced macropinocytosis. Data reported by Stahl and coworkers (Barbieri et al., 1998
) suggested that Ras facilitates endocytosis of EGF-EGFR, possibly by activation of Rab5 upon incubation of cells with 600 ng/ml EGF. It has previously also been reported that Grb2 has a role in events associated with a macropinocytic internalization pathway for EGFR (Yamazaki et al., 2002
). We therefore conclude that Grb2 seems to be involved both in clathrin-dependent and -independent endocytosis of the EGFR. The role of Grb2 in clathrin-independent endocytosis could potentially be to activate Ras, whereas the requirement for Grb2 in EGF-induced clathrin-dependent endocytosis is not explained by a requirement for Ras activity.
The EGFR may by binding Grb2 and Cbl, initially be recruited to a molecular complex containing Eps15, located at the rim of coated pits. This complex could consist of Eps15, epsin, RalBP1, POB1, and AP-2 as suggested (Nakashima et al., 1999
). The fact that POB1 has been demonstrated to bind Grb2 (Ikeda et al., 1998
) makes POB1 an attractive candidate for linking the EGFR-Grb2-Cbl complex to the rim of coated pits. Dynamin was found to decorate the whole cytosolic part of coated pits, and it is unlikely that dynamin is responsible for the EGF-induced recruitment of Grb2 to coated pits. Grb2 could preferentially bind dynamin in the GTP-bound form, which potentially could localize close to the rim of the coat. However, our unpublished studies have shown that Grb2 also localizes to the rim of coated pits in HeLa cells that inducibly overexpress dynamin K44A, reportedly incapable of binding GTP (Damke et al., 1994
). Eps15 has further been demonstrated to bind Crk (Schumacher et al., 1995
), which can again interact with the EGFR (Moran et al., 1990
; Birge et al., 1992
) as well as with Cbl (Fukazawa et al., 1996
). In a more or less defined complex containing Grb2, Cbl, and Eps15 at the rim of coated pits, autophosphorylated EGFR becomes ubiquitinated by Cbl. We have now demonstrated that also hSpry2, in addition to Grb2, Cbl, and Eps15, localizes at the rim of clathrin-coated pits in cells transfected with GFP-tagged hSpry2. There is reason to believe that hSpry2 under physiological conditions interacts with Cbl at the rim of clathrin-coated pits and in this way modulates the speed by which the activated EGFR is translocated to clathrin-coated pits by fine-tuning the ubiquitination.
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| Footnotes |
|---|
Abbreviations used: EGFR, EGF receptor; SAB, sodium acetate buffer; Tf, transferrin; TfR, transferrin receptor; UIM, ubiquitin-interacting motif.
These authors contributed equally to this work. ![]()
Corresponding author. E-mail address: i.h.madshus{at}labmed.uio.no.
| REFERENCES |
|---|
|
|
|---|
Alam, S.L., Sun, J., Payne, M., Welch, B.D., Blake, B.K., Davis, D.R., Meyer, H.H., Emr, S.D., and Sundquist, W.I. ((2004). ). Ubiquitin interactions of NZF fingers. EMBO J. 23, , 1411-1421.[CrossRef][Medline]
Amyere, M., Mettlen, M., Van Der Smissen, P., Platek, A., Payrastre, B., Veithen, A., and Courtoy, P.J. ((2002). ). Origin, originality, functions, subversions and molecular signalling of macropinocytosis. Int. J. Med. Microbiol. 291, , 487-494.[CrossRef][Medline]
Barbieri, M.A., Kohn, A.D., Roth, R.A., and Stahl, P.D. ((1998). ). Protein kinase B/akt and rab5 mediate Ras activation of endocytosis. J. Biol. Chem. 273, , 19367-19370.
Beal, R., Deveraux, Q., Xia, G., Rechsteiner, M., and Pickart, C. ((1996). ). Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting. Proc. Natl. Acad. Sci. USA 93, , 861-866.
Benmerah, A., Lamaze, C., Begue, B., Schmid, S.L., Dautry-Varsat, A., and Cerf-Bensussan, N. ((1998). ). AP-2/Eps15 interaction is required for receptor-mediated endocytosis. J. Cell Biol. 140, , 1055-1062.
Birge, R.B., Fajardo, J.E., Mayer, B.J., and Hanafusa, H. ((1992). ). Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro. J. Biol. Chem. 267, , 10588-10595.
Chardin, P., Camonis, J.H., Gale, N.W., van Aelst, L., Schlessinger, J., Wigler, M.H., and Bar-Sagi, D. ((1993). ). Human Sos 1, a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260, , 1338-1343.
Chen, H., Fre, S., Slepnev, V.I., Capua, M.R., Takei, K., Butler, M.H., Di Fiore, P.P., and De Camilli, P. ((1998). ). Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. Nature 394, , 793-797.[CrossRef][Medline]
Ciechanover, A., Schwartz, A.L., Dautry-Varsat, A., and Lodish, H.F. ((1983). ). Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. J. Biol. Chem. 258, , 9681-9689.
Conner, S.D., and Schmid, S.L. ((2003). ). Differential requirements for AP-2 in clathrin-mediated endocytosis. J. Cell Biol. 162, , 773-779.
Damke, H., Baba, T., Warnock, D.E., and Schmid, S.L. ((1994). ). Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell Biol. 127, , 915-934.
Duan, L. et al. ((2003). ). Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis. J. Biol. Chem. 278, , 28950-28960.
Evan, G.I., Lewis, G.K., Ramsay, G., and Bishop, J.M. ((1985). ). Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5, , 3610-3616.
Fong, C.W., Leong, H.F., Wong, E.S., Lim, J., Yusoff, P., and Guy, G.R. ((2003). ). Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function. J. Biol. Chem. 278, , 33456-33464.
Ford, M.G., Mills, I.G., Peter, B.J., Vallis, Y., Praefcke, G.J., Evans, P.R., and McMahon, H.T. ((2002). ). Curvature of clathrin-coated pits driven by epsin. Nature 419, , 361-366.[CrossRef][Medline]
Fukazawa, T., Miyake, S., Band, V., and Band, H. ((1996). ). Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J. Biol. Chem. 271, , 14554-14559.
Griffiths, G., McDowall, A., Back, R., and Dubochet, J. ((1984). ). On the preparation of cryosections for immunocytochemistry. J. Ultrastruct. Res. 89, , 65-78.[CrossRef][Medline]
Haglund, K., Sigismund, S., Polo, S., Szymkiewicz, I., Di Fiore, P.P., and Dikic, I. ((2003). ). Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat. Cell Biol. 5, , 461-466.[CrossRef][Medline]
Huang, K.M., D'Hondt, K., Riezman, H., and Lemmon, S.K. ((1999). ). Clathrin functions in the absence of heterotetrameric adaptors and AP180-related proteins in yeast. EMBO J. 18, , 3897-3908.[CrossRef][Medline]
Ikeda, M., Ishida, O., Hinoi, T., Kishida, S., and Kikuchi, A. ((1998). ). Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral. J. Biol. Chem. 273, , 814-821.
Jain, S.K., Langdon, W.Y., and Varticovski, L. ((1997). ). Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase. Oncogene 14, , 2217-2228.[CrossRef][Medline]
Jiang, X., Huang, F., Marusyk, A., and Sorkin, A. ((2003). ). Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol. Biol. Cell 14, , 858-870.
Jiang, X., and Sorkin, A. ((2003). ). Epidermal growth factor receptor internalization through clathrin-coated pits requires Cbl RING finger and proline-rich domains but not receptor polyubiquitylation. Traffic 4, , 529-543.[Medline]
Kang, R.S., Daniels, C.M., Francis, S.A., Shih, S.C., Salerno, W.J., Hicke, L., and Radhakrishnan, I. ((2003). ). Solution structure of a CUE-ubiquitin complex reveals a conserved mode of ubiquitin binding. Cell 113, , 621-630.[CrossRef][Medline]
Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin, P., Bar-Sagi, D., Margolis, B., and Schlessinger, J. ((1993). ). Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363, , 85-88.[CrossRef][Medline]
Lill, N.L., Douillard, P., Awwad, R.A., Ota, S., Lupher, M.L., Jr., Miyake, S., Meissner-Lula, N., Hsu, V.W., and Band, H. ((2000). ). The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor. J. Biol. Chem. 275, , 367-377.
Longva, K.E., Blystad, F.D., Stang, E., Larsen, A.M., Johannessen, L.E., and Madshus, I.H. ((2002). ). Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 156, , 843-854.
Lund, K.A., Opresko, L.K., Starbuck, C., Walsh, B.J., and Wiley, H.S. ((1990). ). Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. J. Biol. Chem. 265, , 15713-15723.
Moran, M.F., Koch, C.A., Anderson, D., Ellis, C., England, L., Martin, G.S., and Pawson, T. ((1990). ). Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl. Acad. Sci. USA 87, , 8622-8626.
Mosesson, Y., Shtiegman, K., Katz, M., Zwang, Y., Vereb, G., Szollosi, J., and Yarden, Y. ((2003). ). Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation. J. Biol. Chem. 278, , 21323-21326.
Motley, A., Bright, N.A., Seaman, M.N., and Robinson, M.S. ((2003). ). Clathrin-mediated endocytosis in AP-2-depleted cells. J. Cell Biol. 162, , 909-918.
Nakashima, S., Morinaka, K., Koyama, S., Ikeda, M., Kishida, M., Okawa, K., Iwamatsu, A., Kishida, S., and Kikuchi, A. ((1999). ). Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors. EMBO J. 18, , 3629-3642.[CrossRef][Medline]
Nesterov, A., Carter, R.E., Sorkina, T., Gill, G.N., and Sorkin, A. ((1999). ). Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis. EMBO J. 18, , 2489-2499.[CrossRef][Medline]
Olivier, J.P., Raabe, T., Henkemeyer, M., Dickson, B., Mbamalu, G., Margolis, B., Schlessinger, J., Hafen, E., and Pawson, T. ((1993). ). A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of Ras guanine nucleotide exchange, Sos. Cell 73, , 179-191.[CrossRef][Medline]
Polo, S., Sigismund, S., Faretta, M., Guidi, M., Capua, M.R., Bossi, G., Chen, H., De Camilli, P., and Di Fiore, P.P. ((2002). ). A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature 416, , 451-455.[CrossRef][Medline]
Raiborg, C., Bremnes, B., Mehlum, A., Gillooly, D.J., D'Arrigo, A., Stang, E., and Stenmark, H. ((2001). ). FYVE and coiled-coil domains determine the specific localisation of Hrs to early endosomes. J. Cell Sci. 114, , 2255-2263.
Schmidt, M.H., Furnari, F.B., Cavenee, W.K., and Bogler, O. ((2003). ). Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization. Proc. Natl. Acad. Sci. USA 100, , 6505-6510.
Schumacher, C., Knudsen, B.S., Ohuchi, T., Di Fiore, P.P., Glassman, R.H., and Hanafusa, H. ((1995). ). The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R. J. Biol. Chem. 270, , 15341-15347.
Shiba, Y., Katoh, Y., Shiba, T., Yoshino, K., Takatsu, H., Kobayashi, H., Shin, H.W., Wakatsuki, S., and Nakayama, K. ((2004). ). GAT (GGA and Tom1) domain responsible for ubiquitin binding and ubiquitination. J. Biol. Chem. 279, , 7105-7111.
Shih, S.C., Katzmann, D.J., Schnell, J.D., Sutanto, M., Emr, S.D., and Hicke, L. ((2002). ). Epsins and Vps27p/Hrs contain ubiquitin-binding domains that function in receptor endocytosis. Nat. Cell Biol. 4, , 389-393.[CrossRef][Medline]
Sorkina, T., Huang, F., Beguinot, L., and Sorkin, A. ((2002). ). Effect of tyrosine kinase inhibitors on clathrin-coated pit recruitment and internalization of epidermal growth factor receptor. J. Biol. Chem. 277, , 27433-27441.
Soubeyran, P., Kowanetz, K., Szymkiewicz, I., Langdon, W.Y., and Dikic, I. ((2002). ). Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416, , 183-187.[CrossRef][Medline]
Stang, E., Johannessen, L.E., Knardal, S.L., and Madshus, I.H. ((2000). ). Polyubiquitination of the epidermal growth factor receptor occurs at the plasma membrane upon ligand-induced activation. J. Biol. Chem. 275, , 13940-13947.
Tall, G.G., Barbieri, M.A., Stahl, P.D., and Horazdovsky, B.F. ((2001). ). Ras-activated endocytosis is mediated by the Rab5 guanine nucleotide exchange activity of RIN1. Dev. Cell 1, , 73-82.[CrossRef][Medline]
Tanaka, M., Gupta, R., and Mayer, B.J. ((1995). ). Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol. Cell. Biol. 15, , 6829-6837.[Abstract]
Tebar, F., Sorkina, T., Sorkin, A., Ericsson, M., and Kirchhausen, T. ((1996). ). Eps15 is a component of clathrin-coated pits and vesicles and is located at the rim of coated pits. J. Biol. Chem. 271, , 28727-28730.
Thien, C.B., Walker, F., and Langdon, W.Y. ((2001). ). RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Mol. Cell 7, , 355-365.[CrossRef][Medline]
Torrisi, M.R., Lotti, L.V., Belleudi, F., Gradini, R., Salcini, A.E., Confalonieri, S., Pelicci, P.G., and Di Fiore, P.P. ((1999). ). Eps15 is recruited to the plasma membrane upon epidermal growth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization. Mol. Biol. Cell 10, , 417-434.
Wang, Z., and Moran, M.F. ((1996). ). Requirement for the adapter protein GRB2 in EGF receptor endocytosis. Science 272, , 1935-1939.[Abstract]
Waterman, H., Katz, M., Rubin, C., Shtiegman, K., Lavi, S., Elson, A., Jovin, T., and Yarden, Y. ((2002). ). A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling. EMBO J. 21, , 303-313.[CrossRef][Medline]
Wendland, B. ((2002). ). Epsins: adaptors in endocytosis? Nat Rev Mol. Cell. Biol. 3, , 971-977.[CrossRef][Medline]
Wiley, H.S., Woolf, M.F., Opresko, L.K., Burke, P.M., Will, B., Morgan, J.R., and Lauffenburger, D.A. ((1998). ). Removal of the membrane-anchoring domain of epidermal growth factor leads to intracrine signaling and disruption of mammary epithelial cell organization. J. Cell Biol. 143, , 1317-1328.
Wong, E.S., Fong, C.W., Lim, J., Yusoff, P., Low, B.C., Langdon, W.Y., and Guy, G.R. ((2002). ). Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO J. 21, , 4796-4808.[CrossRef][Medline]
Yamazaki, T., Zaal, K., Hailey, D., Presley, J., Lippincott-Schwartz, J., and Samelson, L.E. ((2002). ). Role of Grb2 in EGF-stimulated EGFR internalization. J. Cell Sci. 115, , 1791-1802.
This article has been cited by other articles:
![]() |
C. A. Parachoniak and M. Park Distinct Recruitment of Eps15 via Its Coiled-coil Domain Is Required For Efficient Down-regulation of the Met Receptor Tyrosine Kinase J. Biol. Chem., March 27, 2009; 284(13): 8382 - 8394. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Marois, M. Vaillancourt, S. Marois, S. Proulx, G. Pare, E. Rollet-Labelle, and P. H. Naccache The Ubiquitin Ligase c-Cbl Down-Regulates Fc{gamma}RIIa Activation in Human Neutrophils J. Immunol., February 15, 2009; 182(4): 2374 - 2384. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Pedersen, K. Breen, M. S. Rodland, C. Haslekas, E. Stang, and I. H. Madshus Expression of Epidermal Growth Factor Receptor or ErbB3 Facilitates Geldanamycin-Induced Down-Regulation of ErbB2 Mol. Cancer Res., February 1, 2009; 7(2): 275 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hayashi and Y. Sugiyama Short-Chain Ubiquitination Is Associated with the Degradation Rate of a Cell-Surface-Resident Bile Salt Export Pump (BSEP/ABCB11) Mol. Pharmacol., January 1, 2009; 75(1): 143 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Barr, A. G. Ostermeyer-Fay, R. A. Matundan, and D. A. Brown Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells J. Cell Sci., October 1, 2008; 121(19): 3155 - 3166. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Deb, C. M. Coticchia, R. Barndt, H. Zuo, R. B. Dickson, and M. D. Johnson Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation Am J Physiol Cell Physiol, August 1, 2008; 295(2): C365 - C377. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Haugsten, J. Malecki, S. M. S. Bjorklund, S. Olsnes, and J. Wesche Ubiquitination of Fibroblast Growth Factor Receptor 1 Is Required for Its Intracellular Sorting but Not for Its Endocytosis Mol. Biol. Cell, August 1, 2008; 19(8): 3390 - 3403. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pennock and Z. Wang A Tale of Two Cbls: Interplay of c-Cbl and Cbl-b in Epidermal Growth Factor Receptor Downregulation Mol. Cell. Biol., May 1, 2008; 28(9): 3020 - 3037. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Roxrud, C. Raiborg, N. M. Pedersen, E. Stang, and H. Stenmark An endosomally localized isoform of Eps15 interacts with Hrs to mediate degradation of epidermal growth factor receptor J. Cell Biol., March 24, 2008; 180(6): 1205 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Lee, T. C. Wheeler, L. Li, and L.-S. Chin Ubiquitination of {alpha}-synuclein by Siah-1 promotes {alpha}-synuclein aggregation and apoptotic cell death Hum. Mol. Genet., March 15, 2008; 17(6): 906 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Pedersen, I. H. Madshus, C. Haslekas, and E. Stang Geldanamycin-Induced Down-Regulation of ErbB2 from the Plasma Membrane Is Clathrin Dependent but Proteasomal Activity Independent Mol. Cancer Res., March 1, 2008; 6(3): 491 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Taub, D. Teis, H. L. Ebner, M. W. Hess, and L. A. Huber Late Endosomal Traffic of the Epidermal Growth Factor Receptor Ensures Spatial and Temporal Fidelity of Mitogen-activated Protein Kinase Signaling Mol. Biol. Cell, December 1, 2007; 18(12): 4698 - 4710. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Huang, L. K. Goh, and A. Sorkin EGF receptor ubiquitination is not necessary for its internalization PNAS, October 23, 2007; 104(43): 16904 - 16909. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Inoue, N. Tanaka, Y. Tanaka, S. Inoue, K. Morita, M. Zhuang, T. Hattori, and K. Sugamura Clathrin-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus into Target Cells Expressing ACE2 with the Cytoplasmic Tail Deleted J. Virol., August 15, 2007; 81(16): 8722 - 8729. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Grandal, R. Zandi, M. W. Pedersen, B. M. Willumsen, B. van Deurs, and H. S. Poulsen EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes Carcinogenesis, July 1, 2007; 28(7): 1408 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Curto, B. K. Cole, D. Lallemand, C.-H. Liu, and A. I. McClatchey Contact-dependent inhibition of EGFR signaling by Nf2/Merlin J. Cell Biol., June 21, 2007; 177(5): 893 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Li, M. Lorinczi, K. Ireton, and L. A. Elferink Specific Grb2-mediated Interactions Regulate Clathrin-dependent Endocytosis of the cMet-tyrosine Kinase J. Biol. Chem., June 8, 2007; 282(23): 16764 - 16775. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T.-Y. Wong, C.-C. Hon, F. Zeng, and F. C.-C. Leung Screening of differentially expressed transcripts in infectious bursal disease virus-induced apoptotic chicken embryonic fibroblasts by using cDNA microarrays J. Gen. Virol., June 1, 2007; 88(6): 1785 - 1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maegawa, K. Takeuchi, E. Funakoshi, K. Kawasaki, K. Nishio, N. Shimizu, and F. Ito Growth Stimulation of Non-Small Cell Lung Cancer Cell Lines by Antibody against Epidermal Growth Factor Receptor Promoting Formation of ErbB2/ErbB3 Heterodimers Mol. Cancer Res., April 1, 2007; 5(4): 393 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Traub and G. L. Lukacs Decoding ubiquitin sorting signals for clathrin-dependent endocytosis by CLASPs J. Cell Sci., February 15, 2007; 120(4): 543 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bonaccorsi, D. Nosi, M. Muratori, L. Formigli, G. Forti, and E. Baldi Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines J. Mol. Endocrinol., January 1, 2007; 38(1): 51 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Martin, R. P. Mohney, S. Dunn, M. Das, E. Scappini, and J. P. O'Bryan Intersectin Regulates Epidermal Growth Factor Receptor Endocytosis, Ubiquitylation, and Signaling Mol. Pharmacol., November 1, 2006; 70(5): 1643 - 1653. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Staub and D. Rotin Role of Ubiquitylation in Cellular Membrane Transport Physiol Rev, April 1, 2006; 86(2): 669 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ren, P. Vajjhala, J. S. Lee, B. Winsor, and A. L. Munn The BAR Domain Proteins: Molding Membranes in Fission, Fusion, and Phagy Microbiol. Mol. Biol. Rev., March 1, 2006; 70(1): 37 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Johannessen, N. M. Pedersen, K. W. Pedersen, I. H. Madshus, and E. Stang Activation of the epidermal growth factor (EGF) receptor induces formation of EGF receptor- and Grb2-containing clathrin-coated pits. Mol. Cell. Biol., January 1, 2006; 26(2): 389 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Abella, P. Peschard, M. A. Naujokas, T. Lin, C. Saucier, S. Urbe, and M. Park Met/Hepatocyte Growth Factor Receptor Ubiquitination Suppresses Transformation and Is Required for Hrs Phosphorylation Mol. Cell. Biol., November 1, 2005; 25(21): 9632 - 9645. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Slagsvold, R. Aasland, S. Hirano, K. G. Bache, C. Raiborg, D. Trambaiolo, S. Wakatsuki, and H. Stenmark Eap45 in Mammalian ESCRT-II Binds Ubiquitin via a Phosphoinositide-interacting GLUE Domain J. Biol. Chem., May 20, 2005; 280(20): 19600 - 19606. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mishra, P. A. Keyel, M. A. Edeling, A. L. Dupin, D. J. Owen, and L. M. Traub Functional Dissection of an AP-2 {beta}2 Appendage-binding Sequence within the Autosomal Recessive Hypercholesterolemia Protein J. Biol. Chem., May 13, 2005; 280(19): 19270 - 19280. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Huang and A. Sorkin Growth Factor Receptor Binding Protein 2-mediated Recruitment of the RING Domain of Cbl to the Epidermal Growth Factor Receptor Is Essential and Sufficient to Support Receptor Endocytosis Mol. Biol. Cell, March 1, 2005; 16(3): 1268 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sigismund, T. Woelk, C. Puri, E. Maspero, C. Tacchetti, P. Transidico, P. P. Di Fiore, and S. Polo From the Cover: Clathrin-independent endocytosis of ubiquitinated cargos PNAS, February 22, 2005; 102(8): 2760 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suzuki-Hirano, T. Sato, and H. Nakamura Regulation of isthmic Fgf8 signal by sprouty2 Development, January 15, 2005; 132(2): 257 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. de Melker, G. van der Horst, and J. Borst Ubiquitin Ligase Activity of c-Cbl Guides the Epidermal Growth Factor Receptor into Clathrin-coated Pits by Two Distinct Modes of Eps15 Recruitment J. Biol. Chem., December 31, 2004; 279(53): 55465 - 55473. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Kinlough, P. A. Poland, J. B. Bruns, K. L. Harkleroad, and R. P. Hughey MUC1 Membrane Trafficking Is Modulated by Multiple Interactions J. Biol. Chem., December 17, 2004; 279(51): 53071 - 53077. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mishra, M. J. Hawryluk, T. J. Brett, P. A. Keyel, A. L. Dupin, A. Jha, J. E. Heuser, D. H. Fremont, and L. M. Traub Dual Engagement Regulation of Protein Interactions with the AP-2 Adaptor {alpha} Appendage J. Biol. Chem., October 29, 2004; 279(44): 46191 - 46203. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||